| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT05309421 | A Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Adults With Unresectable or Metastatic Melanoma | ACTIVE_NOT_RECRUITING | PHASE2 | 2022-09-19 | 2026-03-30 | 2025-09-30 |
| NCT04455503 | Study of Adjuvant Immunotherapy With EVX-02 and Anti-PD-1 | TERMINATED | PHASE1, PHASE2 | 2020-07-13 | 2023-03-28 | 2023-02-28 |